Stereotactic body radiotherapy plus sorafenib led to a strong survival benefit vs sorafenib alone in advanced hepatocellular carcinoma.
MDedge News
Stereotactic body radiotherapy plus sorafenib led to a strong survival benefit vs sorafenib alone in advanced hepatocellular carcinoma.
MDedge News